×

Top News & Analysis Massachusetts

  • BOSTON _ LPL Financial Holdings Inc. on Thursday reported second-quarter earnings of $68.4 million. The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of 66 cents per share. LPL Financial shares have climbed 28 percent since the beginning of the year.

  • BEVERLY, Mass. _ Atlantic Tele-Network Inc. on Thursday reported second-quarter net income of $5.9 million, after reporting a loss in the same period a year earlier. Atlantic Tele-Network shares have decreased 17 percent since the beginning of the year. Keywords: Atlantic Tele-Network, Earnings Report.

  • HOLLISTON, Mass. _ Harvard Bioscience Inc. on Thursday reported a loss of $381,000 in its second quarter. Harvard Bioscience expects full-year earnings in the range of 13 cents to 15 cents per share. Keywords: Harvard Bioscience, Earnings Report.

  • BOSTON _ LogMein Inc. on Thursday reported second-quarter net income of $14.8 million. Six analysts surveyed by Zacks expected $264.9 million. For the current quarter ending in October, LogMein expects its per-share earnings to range from $1.10 to $1.12.

  • SPRINGFIELD, Mass. _ Eversource Energy on Thursday reported second-quarter net income of $230.7 million. The average estimate of six analysts surveyed by Zacks Investment Research was for earnings of 68 cents per share. This story was generated by Automated Insights using data from Zacks Investment Research.

  • One of the main reasons GOP lawmakers have given in their quest to overturn "Obamacare" is that they want to lower premiums for people who buy individual health insurance policies, particularly constituents who get no help from the law's tax credits. "There is no doubt whatsoever that premiums in the individual insurance market would go up," said Larry Levitt of...

  • July 27- The publisher of marijuana enthusiast magazine, "High Times," plans to take the company public, High Times Holding Corp announced Thursday, as an increasing number of U.S. states legalize the drug. Oreva Capital, which in June announced it had bought a controlling stake in High Times for $70 million, is selling the company to special purpose acquisition...

  • July 27- Dunkin' Donuts will not match McDonald's $1 coffee specials in the United States, where fast-food restaurants are brawling for every sale amid intense competition from direct rivals, convenience stores and other food sellers. U.S. Dunkin' Donuts shops will offer a variety of local and national promotions, but will not aggressively discount the product...

  • Raytheon's shares were down 0.38 percent at $168.24 on the New York Stock Exchange in late morning trading. The Waltham, Massachusetts- based weapons maker raised its 2017 sales forecast by about $200 million to between $25.1 billion and $25.6 billion, and its expectation for earnings from continuing operations by 10 cents to a range of $7.35 to $7.50 per share,...

  • July 27- The publisher of marijuana enthusiast magazine, "High Times," plans to take the company public, High Times Holding Corp announced Thursday, as an increasing number of U.S. states legalize the drug. Oreva Capital, which in June announced it had bought a controlling stake in High Times for $70 million, is selling the company to special purpose acquisition...

  • BOSTON _ CRA International Inc. on Thursday reported second-quarter net income of $3.8 million. On a per-share basis, the Boston- based company said it had net income of 44 cents. Keywords: CRA International, Earnings Report.

  • To bolster its position in the TAVR market in Europe, Boston Scientific in May bought Swiss medical device maker Symetis SA- the fourth-largest player in the multi-billion dollar market- for $435 million. The deal came after Boston Scientific's February recall of its Lotus heart valve devices from Europe and other regions following reports of a faulty...

  • BOSTON— Keryx Biopharmaceuticals Inc. on Thursday reported a loss of $86.5 million in its second quarter. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 17 cents per share. Three analysts surveyed by Zacks expected $14.1 million.

  • DANVERS, Mass. _ Abiomed Inc. on Thursday reported fiscal first-quarter earnings of $37.4 million. The average estimate of six analysts surveyed by Zacks Investment Research was for earnings of 42 cents per share. Three analysts surveyed by Zacks expected $129.7 million.

  • That spurred the Waltham, Massachusetts- based weapons maker to raise its 2017 sales forecast by about $200 million to between $25.1 billion and $25.6 billion, and its expectation for earnings from continuing operations by 10 cents to a range of $7.35 to $7.50 per share, O'Brien said. Raytheon, which also makes the Patriot missile system, said sales in its missile...

  • WESTFORD, Mass. _ NetScout Systems Inc. on Thursday reported a loss of $24.2 million in its fiscal first quarter. The average estimate of four analysts surveyed by Zacks Investment Research was also for earnings of 8 cents per share. NetScout shares have risen almost 7 percent since the beginning of the year.

  • BOSTON _ American Tower Corp. on Thursday reported a key measure of profitability in its second quarter. The average estimate of eight analysts surveyed by Zacks Investment Research was for funds from operations of $1.61 per share. American Tower expects full-year revenue in the range of $6.48 billion to $6.58 billion.

  • Sales in Boston Scientific's cardiovascular unit- its biggest by revenue- rose 4.7 percent to $876 million in the second quarter ended June 30. Boston Scientific, which closed a $435 million acquisition of Swiss medical device maker Symetis SA in May, posted net profit of $146 million, or 11 cents per share, compared with a net loss of $207 million, or 15 cents per...

  • WALTHAM, Mass. _ Raytheon Co. on Thursday reported second-quarter net income of $553 million. The average estimate of nine analysts surveyed by Zacks Investment Research was for earnings of $1.74 per share. Five analysts surveyed by Zacks expected $6.23 billion.

  • The Waltham, Massachusetts- based weapons maker raised its 2017 sales forecast by about $200 million to $25.1 billion to $25.6 billion, and its expectation for earnings from continuing operations by 10 cents to $7.35 to $7.50 per share. Raytheon said sales in its missile systems unit, its biggest by revenue, climbed 11.4 percent to $1.90 billion in the second...